Asthma trials in Spain

In Spain 47 Also abroad 500

47 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Not yet taking people in Spain
A study that compares Depigoid Olea (a medication to treat olive pollen allergies) and placebo in patients who have a runny nose and pink and itchy eyes due to olive pollen allergy.
Where
Albacete, Alicante, Badajoz, Castello De La Plana, Córdoba, Cuenca, Elche, Granada, Jaén, Jerez de la Frontera, Madrid, Majadahonda, Málaga, Plasencia, Sevilla, Villarreal, Zaragoza
People
300 worldwide
Run by
LETI Pharma S.L.U.
See details and how to join2026-525840-13-00 · EU 2026-525840-13-00
Phase 3Not yet taking people in Spain
Clinical trial to assess the efficacy and safety of a vaccine for grass pollen allergy.
Where
Ponferrada, Salamanca, Santiago de Compostela, Segovia, Valladolid
Age
Up to 64 years
People
171 worldwide
Run by
Inmunotek S.L.
See details and how to join2026-526100-73-00 · EU 2026-526100-73-00
Phase 2Taking people
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Where
Madrid, Málaga, Pozuelo de Alarcón, Santander
Age
18 years to 75 years
People
252 worldwide
Run by
Pfizer
See details and how to joinNCT06977581 · EU 2024-517866-40-00
Phase 4Taking people
A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
Where
Alcorcón, Badalona, Barcelona, Benalmádena, Cáceres, Girona, Lugo, Madrid, Málaga, Santiago de Compostela, Sant Joan d'Alacant, Zaragoza
Age
6 years and over
People
2,500 worldwide
Run by
Sanofi
See details and how to joinNCT07556159 · EU 2025-524916-13-00
Phase 3Taking people
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Where
Barcelona, Huelva, Málaga, Mataró, Seville, Zaragoza
Age
12 years to 80 years
People
786 worldwide
Run by
Generate Biomedicines
See details and how to joinNCT07359846
Phase 2Taking people
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Where
Barcelona, Madrid, Málaga, Santander, Valencia
Age
18 years to 75 years
People
540 worldwide
Run by
AstraZeneca
See details and how to joinNCT06932263 · EU 2024-519116-14-00
Phase 3Taking people
Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis. MM09-SIT-063.
Where
Alicante, Barcelona, Ciudad Real, Málaga, Melilla, San Cristóbal de La Laguna
Age
12 years to 65 years
People
250 worldwide
Run by
Inmunotek S.L.
See details and how to joinNCT07904052
Phase 3Taking people
Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis_MM09-SIT-063.
Where
Alicante, Badajoz, Cadiz, Elche, Las Palmas de Gran Canaria, Málaga, Murcia, Valencia
Age
12 years to 65 years
People
250 worldwide
Run by
Inmunotek S.L.
See details and how to joinNCT07904195
Phase 2Taking people
Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma
Where
A Coruna, Benalmádena, Cadiz, Donostia, Ferrol, Madrid, Málaga, Mataro, Pozuelo de Alarcón, Valencia, Vigo, Zaragoza
Age
18 years to 75 years
People
600 worldwide
Run by
Windward Bio
See details and how to joinNCT07120503 · EU 2025-521391-58-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
Where
Barcelona, Córdoba, Esplugues de Llobregat, Madrid, Málaga, Sabadell
Age
6 years to 11 years
People
200 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05562466 · EU 2022-501899-26-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
Where
Sabadell, Santiago Compostela, Seville
Age
12 years to 17 years
People
188 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05776927
Phase 3Not yet taking people in Spain
Clinical trial to assess the efficacy and safety of a vaccine for dust mite and Blomia tropicalis allergy.
Where
Arrecife, Cádiz, Las Palmas De Gran Canaria, Santa Cruz de Tenerife, Santa Cruz De Tenerife
People
120
Run by
Inmunotek S.L.
See details and how to join2025-522773-12-00 · EU 2025-522773-12-00
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Where
Badalona, Barcelona, Esplugues de Llobregat (Barc), Madrid, Sabadell, Valencia, Villarreal
Age
5 years to 11 years
People
231 worldwide
Run by
AstraZeneca
See details and how to joinNCT06023589
Phase 3Taking people
Multicenter clinical trial to evaluate efficacy and safety of sublingual immunotherapy in patients allergic to house mites, with rhinitis/rhinoconjunctivitis with or without mild to moderate asthma
Where
Alicante, Benidorm
People
147 worldwide
Run by
Inmunotek S.L.
See details and how to join2023-505918-14-00 · EU 2023-505918-14-00
Phase 2Taking people
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Where
Cadiz, Jerez de la Frontera, Madrid, Mataró, Santander
Age
18 years to 75 years
People
264 worldwide
Run by
Kymera Therapeutics, Inc.
See details and how to joinNCT07323654
Phase 3Taking people
PHASE III, DOUBLE-BLIND, RANDOMIZED, CONTROLLED, NON-INFERIORITY, PHASE III CLINICAL TRIAL TO EVALUATE THE EFFICACY OF SALBUTAMOL MONOTHERAPY COMPARED TO SALBUTAMOL PLUS IPRATROPIUM BROMIDE IN THE MANAGEMENT OF MODERATE ACUTE ASTHMATIC EXARCEBATIONS IN CHILDREN IN THE EMERGENCY DEPARTMENT
Where
Barakaldo, Granollers, Madrid, Sevilla
Age
Up to 17 years
People
476
Run by
Fundacion Para La Investigacion Biomedica Hospital Infantil Universitario Nino Jesus
See details and how to join2024-514065-19-00 · EU 2024-514065-19-00
Phase 3Not yet taking people in Spain
Safety and Efficacy Comparison Between CHF5993 100/6 12.5µg pMDI to Seretide Evohaler 125/25µg pMDI in Adolescent Subjects With Asthma
Where
Badalona, Barcelona, Burjassot, Cartagena, Esplugues de Llobregat, Jerez de la Frontera, Leganés, Madrid, Santiago de Compostela
Age
12 years to 17 years
People
700 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07858123 · EU 2024-514248-95-00
Phase 3Not yet taking people in Spain
Clinical trial to assess the efficacy and safety of a vaccine for olive pollen allergy
Where
Córdoba, Granada, Jaén, Madrid, Sevilla
Age
Up to 64 years
People
120
Run by
Inmunotek S.L.
See details and how to join2026-526390-41-00 · EU 2026-526390-41-00
Phase 2Not yet taking people in Spain
A Long-term Study of KT-621 Administered Orally to Participants with Asthma Previously Enrolled in a KT-621 Asthma Study
Where
Cadiz, Jerez de la Frontera, Madrid, Mataro, San Cristobal De La Laguna, Santander
Age
18 years and over
People
77 worldwide
Run by
Kymera Therapeutics Inc.
See details and how to join2026-526241-98-00 · EU 2026-526241-98-00
No phaseTaking people
Effect of CPAP Treatment in Patients With Severe Uncontrolled Asthma: The ASTHMA-SLEEP Trial
Where
Barcelona
Age
18 years and over
People
138
Run by
Hospital Clinic of Barcelona
See details and how to joinNCT06314477
Phase 2Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Where
Badalona, Barcelona, Benalmádena, Girona, Madrid, Málaga, Palma, Santander, Santiago de Compostela, Sevilla
Age
18 years and over
People
900 worldwide
Run by
Sanofi
See details and how to joinNCT06609239 · EU 2025-522896-27-00
No phaseNot yet taking people in Spain
Structured Nursing Intervention for Adults With Poorly Controlled Asthma: A Pilot Study
Where
Madrid
Age
18 years and over
People
30
Run by
Hospital San Carlos, Madrid
See details and how to joinNCT07635537
Phase 3Not yet taking people in Spain
International, multicenter, blinded phase III clinical trial to assess the diagnostic efficacy of the skin prick test from ROXALL (SPT-RX) with different allergen extract solutions for in vivo diagnosis of IgE mediated allergies
Where
Alcázar de San Juan, Alicante, Badajoz, Barcelona, Villarreal, Villarrobledo
Age
18 years to 64 years
People
140 worldwide
Run by
ROXALL Medizin GmbH
See details and how to join2025-524676-32-00 · EU 2025-524676-32-00
Phase 2Taking people
A Study of KT-621 Administered Orally to Adult Participants with Moderate to Severe Eosinophilic Asthma
Where
Cadiz, Jerez de la Frontera, Madrid, Mataro, San Cristobal De La Laguna, Santander
Age
18 years and over
People
121 worldwide
Run by
Kymera Therapeutics Inc.
See details and how to join2025-523180-38-00 · EU 2025-523180-38-00
Phase 2Taking people
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma
Where
Barcelona, Esplugues De Llobregat, Sabadell
Age
6 years to 11 years
People
42 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05222529 · EU 2024-511382-11-00